CLDF Title
Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
NASH-TAG 2016       IC-Hep
  Liver News - REUTERS   Congress Calendar   Physician Resources  
New score helps predict HCC recurrence after liver transplant
High-protein diet may reduce liver fat in patients with NAFLD
Dynavax says FDA rejects its hepatitis B vaccine
Hep C virus NS5A polymorphisms limit efficacy of elbasvir plus grazoprevir
Gilead's hepatitis B drug gets U.S. approval
View Complete News Library
View all Congresses
  Featured Abstracts          
Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras
Building a Community - Academic Partnership to Enhance Hepatitis C Virus Screening
Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis
Generic medications for hepatitis C
Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice
Occupational Health Update: Focus on Preventing the Acquisition of Infections with Pre-exposure Prophylaxis and Postexposure Prophylaxis
Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings
Factors associated with poor adherence to antiviral treatment for hepatitis B
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study
Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy
Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Treatment of Non-Alcoholic Fatty Liver Disease
Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
Patients with Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-stage Liver Disease
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir)
          View All Abstracts  
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2016 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.